Patient-Reported Outcomes and Time to Symptomatic Progression from Papillon: Amivantamab Plus Chemotherapy vs Chemotherapy as First-Line Treatment of Egfr Exon 20 Insertion-Mutated Advanced Nsclc Article Swipe

View

Luis Paz Ares , Rémi Veillon , Margarita Majem , Caicun Zhou , Kejing Tang , Sang-We Kim , Gary Richardson , Nicolas Girard , Rachel E. Sanborn , Aaron S. Mansfield , Keunchil Park , Julia Schuchard , Joris Diels , Jan Sermon , Archan Bhattacharya , Patricia Lorenzini , Honeylet Wortman‐Vayn , Roland E. Knoblauch , Trishala Agrawal , Mahadi Baig , Akira Ono , Joshua K. Sabari ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.2139/ssrn.5318626

Related Topics

Concepts

Chemotherapy Medicine Oncology Exon Internal medicine Gene Biology Genetics

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.2139/ssrn.5318626
OA Status: green
References: 7
Related Works: 10
OpenAlex ID: https://openalex.org/W4412073918

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4412073918

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.2139/ssrn.5318626

Digital Object Identifier
Title: Patient-Reported Outcomes and Time to Symptomatic Progression from Papillon: Amivantamab Plus Chemotherapy vs Chemotherapy as First-Line Treatment of Egfr Exon 20 Insertion-Mutated Advanced Nsclc

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-01-01

Full publication date if available
Authors: Luis Paz Ares, Rémi Veillon, Margarita Majem, Caicun Zhou, Kejing Tang, Sang-We Kim, Gary Richardson, Nicolas Girard, Rachel E. Sanborn, Aaron S. Mansfield, Keunchil Park, Julia Schuchard, Joris Diels, Jan Sermon, Archan Bhattacharya, Patricia Lorenzini, Honeylet Wortman‐Vayn, Roland E. Knoblauch, Trishala Agrawal, Mahadi Baig, Akira Ono, Joshua K. Sabari

List of authors in order
Landing page: https://doi.org/10.2139/ssrn.5318626

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: green

Open access status per OpenAlex
OA URL: https://doi.org/10.2139/ssrn.5318626

Direct OA link when available
Concepts: Chemotherapy, Medicine, Oncology, Exon, Internal medicine, Gene, Biology, Genetics

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
References (count): 7

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4412073918
doi	https://doi.org/10.2139/ssrn.5318626
ids.doi	https://doi.org/10.2139/ssrn.5318626
ids.openalex	https://openalex.org/W4412073918
fwci
type	preprint
title	Patient-Reported Outcomes and Time to Symptomatic Progression from Papillon: Amivantamab Plus Chemotherapy vs Chemotherapy as First-Line Treatment of Egfr Exon 20 Insertion-Mutated Advanced Nsclc
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10417
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	1.0
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Lung Cancer Treatments and Mutations
topics[1].id	https://openalex.org/T12334
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9994999766349792
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Lung Cancer Research Studies
topics[2].id	https://openalex.org/T10202
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9988999962806702
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Lung Cancer Diagnosis and Treatment
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2776694085
concepts[0].level	2
concepts[0].score	0.8114964962005615
concepts[0].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[0].display_name	Chemotherapy
concepts[1].id	https://openalex.org/C71924100
concepts[1].level	0
concepts[1].score	0.7357972264289856
concepts[1].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[1].display_name	Medicine
concepts[2].id	https://openalex.org/C143998085
concepts[2].level	1
concepts[2].score	0.5177880525588989
concepts[2].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[2].display_name	Oncology
concepts[3].id	https://openalex.org/C36823959
concepts[3].level	3
concepts[3].score	0.5005588531494141
concepts[3].wikidata	https://www.wikidata.org/wiki/Q373027
concepts[3].display_name	Exon
concepts[4].id	https://openalex.org/C126322002
concepts[4].level	1
concepts[4].score	0.4451757073402405
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[4].display_name	Internal medicine
concepts[5].id	https://openalex.org/C104317684
concepts[5].level	2
concepts[5].score	0.0759839415550232
concepts[5].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[5].display_name	Gene
concepts[6].id	https://openalex.org/C86803240
concepts[6].level	0
concepts[6].score	0.05474206805229187
concepts[6].wikidata	https://www.wikidata.org/wiki/Q420
concepts[6].display_name	Biology
concepts[7].id	https://openalex.org/C54355233
concepts[7].level	1
concepts[7].score	0.05297166109085083
concepts[7].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[7].display_name	Genetics
keywords[0].id	https://openalex.org/keywords/chemotherapy
keywords[0].score	0.8114964962005615
keywords[0].display_name	Chemotherapy
keywords[1].id	https://openalex.org/keywords/medicine
keywords[1].score	0.7357972264289856
keywords[1].display_name	Medicine
keywords[2].id	https://openalex.org/keywords/oncology
keywords[2].score	0.5177880525588989
keywords[2].display_name	Oncology
keywords[3].id	https://openalex.org/keywords/exon
keywords[3].score	0.5005588531494141
keywords[3].display_name	Exon
keywords[4].id	https://openalex.org/keywords/internal-medicine
keywords[4].score	0.4451757073402405
keywords[4].display_name	Internal medicine
keywords[5].id	https://openalex.org/keywords/gene
keywords[5].score	0.0759839415550232
keywords[5].display_name	Gene
keywords[6].id	https://openalex.org/keywords/biology
keywords[6].score	0.05474206805229187
keywords[6].display_name	Biology
keywords[7].id	https://openalex.org/keywords/genetics
keywords[7].score	0.05297166109085083
keywords[7].display_name	Genetics
language	en
locations[0].id	doi:10.2139/ssrn.5318626
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210172589
locations[0].source.issn	1556-5068
locations[0].source.type	repository
locations[0].source.is_oa	True
locations[0].source.issn_l	1556-5068
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	SSRN Electronic Journal
locations[0].source.host_organization	https://openalex.org/I1318003438
locations[0].source.host_organization_name	RELX Group (Netherlands)
locations[0].source.host_organization_lineage	https://openalex.org/I1318003438
locations[0].license
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.2139/ssrn.5318626
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5074823074
authorships[0].author.orcid
authorships[0].author.display_name	Luis Paz Ares
authorships[0].author_position	first
authorships[0].raw_author_name	Luis Paz Ares
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5066701277
authorships[1].author.orcid
authorships[1].author.display_name	Rémi Veillon
authorships[1].author_position	middle
authorships[1].raw_author_name	Remi Veillon
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5059355812
authorships[2].author.orcid	https://orcid.org/0000-0002-9919-7485
authorships[2].author.display_name	Margarita Majem
authorships[2].author_position	middle
authorships[2].raw_author_name	Margarita Majem
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5029411467
authorships[3].author.orcid	https://orcid.org/0000-0002-1072-9941
authorships[3].author.display_name	Caicun Zhou
authorships[3].author_position	middle
authorships[3].raw_author_name	Caicun Zhou
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5112882311
authorships[4].author.orcid	https://orcid.org/0000-0002-5454-4666
authorships[4].author.display_name	Kejing Tang
authorships[4].author_position	middle
authorships[4].raw_author_name	Ke-Jing Tang
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5110560063
authorships[5].author.orcid
authorships[5].author.display_name	Sang-We Kim
authorships[5].author_position	middle
authorships[5].raw_author_name	Sang-We Kim
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5010965225
authorships[6].author.orcid	https://orcid.org/0000-0003-2122-8285
authorships[6].author.display_name	Gary Richardson
authorships[6].author_position	middle
authorships[6].raw_author_name	Gary Richardson
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5084513212
authorships[7].author.orcid	https://orcid.org/0000-0002-7636-6688
authorships[7].author.display_name	Nicolas Girard
authorships[7].author_position	middle
authorships[7].raw_author_name	Nicolas Girard
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5112238951
authorships[8].author.orcid
authorships[8].author.display_name	Rachel E. Sanborn
authorships[8].author_position	middle
authorships[8].raw_author_name	Rachel E. Sanborn
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5071440718
authorships[9].author.orcid	https://orcid.org/0000-0002-9483-6903
authorships[9].author.display_name	Aaron S. Mansfield
authorships[9].author_position	middle
authorships[9].raw_author_name	Aaron Mansfield
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5030107272
authorships[10].author.orcid	https://orcid.org/0000-0002-4846-7449
authorships[10].author.display_name	Keunchil Park
authorships[10].author_position	middle
authorships[10].raw_author_name	Keunchil Park
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5057651242
authorships[11].author.orcid	https://orcid.org/0000-0002-8613-8961
authorships[11].author.display_name	Julia Schuchard
authorships[11].author_position	middle
authorships[11].raw_author_name	Julia Schuchard
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5014103994
authorships[12].author.orcid	https://orcid.org/0000-0002-9456-9120
authorships[12].author.display_name	Joris Diels
authorships[12].author_position	middle
authorships[12].raw_author_name	Joris Diels
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5081939900
authorships[13].author.orcid
authorships[13].author.display_name	Jan Sermon
authorships[13].author_position	middle
authorships[13].raw_author_name	Jan Sermon
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5111239463
authorships[14].author.orcid
authorships[14].author.display_name	Archan Bhattacharya
authorships[14].author_position	middle
authorships[14].raw_author_name	Archan Bhattacharya
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5067727178
authorships[15].author.orcid
authorships[15].author.display_name	Patricia Lorenzini
authorships[15].author_position	middle
authorships[15].raw_author_name	Patricia Lorenzini
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5071248265
authorships[16].author.orcid
authorships[16].author.display_name	Honeylet Wortman‐Vayn
authorships[16].author_position	middle
authorships[16].raw_author_name	Honeylet Wortman-Vayn
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5042316451
authorships[17].author.orcid
authorships[17].author.display_name	Roland E. Knoblauch
authorships[17].author_position	middle
authorships[17].raw_author_name	Roland E. Knoblauch
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5032586715
authorships[18].author.orcid
authorships[18].author.display_name	Trishala Agrawal
authorships[18].author_position	middle
authorships[18].raw_author_name	Trishala Agrawal
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5059082327
authorships[19].author.orcid	https://orcid.org/0009-0002-4456-8055
authorships[19].author.display_name	Mahadi Baig
authorships[19].author_position	middle
authorships[19].raw_author_name	Mahadi Baig
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5012542775
authorships[20].author.orcid	https://orcid.org/0000-0001-5705-9423
authorships[20].author.display_name	Akira Ono
authorships[20].author_position	middle
authorships[20].raw_author_name	Akira Ono
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5024203424
authorships[21].author.orcid	https://orcid.org/0000-0002-1556-1543
authorships[21].author.display_name	Joshua K. Sabari
authorships[21].author_position	last
authorships[21].raw_author_name	Joshua Sabari
authorships[21].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.2139/ssrn.5318626
open_access.oa_status	green
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Patient-Reported Outcomes and Time to Symptomatic Progression from Papillon: Amivantamab Plus Chemotherapy vs Chemotherapy as First-Line Treatment of Egfr Exon 20 Insertion-Mutated Advanced Nsclc
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10417
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	1.0
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Lung Cancer Treatments and Mutations
related_works	https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.2139/ssrn.5318626
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210172589
best_oa_location.source.issn	1556-5068
best_oa_location.source.type	repository
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	1556-5068
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	SSRN Electronic Journal
best_oa_location.source.host_organization	https://openalex.org/I1318003438
best_oa_location.source.host_organization_name	RELX Group (Netherlands)
best_oa_location.source.host_organization_lineage	https://openalex.org/I1318003438
best_oa_location.license
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.2139/ssrn.5318626
primary_location.id	doi:10.2139/ssrn.5318626
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210172589
primary_location.source.issn	1556-5068
primary_location.source.type	repository
primary_location.source.is_oa	True
primary_location.source.issn_l	1556-5068
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	SSRN Electronic Journal
primary_location.source.host_organization	https://openalex.org/I1318003438
primary_location.source.host_organization_name	RELX Group (Netherlands)
primary_location.source.host_organization_lineage	https://openalex.org/I1318003438
primary_location.license
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.2139/ssrn.5318626
publication_date	2025-01-01
publication_year	2025
referenced_works	https://openalex.org/W4214718761, https://openalex.org/W2801651204, https://openalex.org/W4387844767, https://openalex.org/W4399706539, https://openalex.org/W2162420979, https://openalex.org/W2167571044, https://openalex.org/W1947168884
referenced_works_count	7
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	22
citation_normalized_percentile.value	0.41461158
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False